1. Germany Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Carl Zeiss Meditec AG

Carl Zeiss Meditec AG

AFX.DE
Carl Zeiss Meditec AGDE flagDeutsche Börse
26.24
EUR
+0.14
- -
2.30BMarket Cap
Carl Zeiss Meditec AG
AFX.DE
(Deutsche Börse)

Recent

price

26.24

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
8.32
9.33
10.6
11.15
11.18
12.79
13.39
13.9
14.32
16.32
14.93
18.41
21.27
23.36
23.25
25.45
25.55
Revenue per Share
0.73
0.82
0.88
1.13
0.92
0.77
1.21
1.57
1.41
1.79
1.37
2.64
3.29
3.25
2.01
1.61
1.62
Basic EPS, GAAP
0.66
0.33
0.95
0.66
0.55
0.49
1.03
-0.02
1.7
1.93
1.49
3.32
1.19
1.53
1.07
1.52
2.41
Free Cash Flow per Basic Share
0.18
0.55
0.3
0.4
0.45
0.4
0.38
0.44
0.55
0.55
0.65
0.5
0.9
1.1
1.11
0.6
- -
Dividend per Share
3.36
3.51
4.21
4.97
5.44
5.81
6.64
7.53
8.07
9.33
10.04
12.19
14.57
16.72
17.74
19.02
19.09
Book Value per Share
5.56
6.11
6.8
7.15
6.81
7.23
7.78
11.67
11.79
10.45
10.95
13.36
15.21
16.74
4.13
5.66
5.68
Tangible Book Value per Share
81
81
81
81
81
81
81
86
89
89
89
89
89
89
89
88
87
Basic Weighted Avg Shares
677
759
862
906
909
1,040
1,088
1,190
1,281
1,459
1,335
1,647
1,903
2,089
2,066
2,228
2,228
Sales/Revenue/Turnover
12.81
13.65
14.26
14.63
13.28
12.56
14.18
14.48
15.39
18.14
13.3
22.69
20.86
16.66
9.41
10.02
10.03
Operating Margin (%)
21
19
18
19
18
19
20
24
31
48
60
62
70
74
133
126
- -
Depreciation Expense
60
67
72
92
75
62
98
134
126
160
122
236
294
290
179
141
141
Net Income, GAAP
28.14
28.36
34.25
32.88
30.89
35.55
29.58
27.99
29.55
30.14
30.94
29.95
26.66
29.22
25.21
26.59
26.56
Effective Tax Rate (%)
8.81
8.82
8.34
10.16
8.24
5.99
9.03
11.3
9.87
10.95
9.16
14.35
15.45
13.9
8.65
6.34
6.34
Profit Margin (%)
433
468
495
528
496
533
573
892
971
965
995
1,156
1,253
1,350
639
728
728
Working Capital
9
24
14
12
10
9
6
3
7
43
53
102
106
134
127
108
108
LT Debt
599
634
696
715
754
797
851
1,242
1,315
1,417
1,451
1,677
2,030
2,173
2,056
2,128
2,128
Total Equity
10.49
11.46
11.49
12
10.92
10.5
12.74
11.62
10.71
13.06
8.11
15.63
14.56
10.84
6.32
7.24
7.24
Return on Invested Capital (%)
20.36
20.12
18.82
20.73
15.33
11.9
17.57
21.12
17.97
19.79
14.83
21.81
22.35
19.26
11.7
8.99
8.99
Return on Capital (%)
23.57
23.98
22.9
24.68
17.71
13.62
19.44
22.7
18.51
20.53
14.13
23.77
24.56
20.75
11.64
8.72
8.72
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
ST Debt
25
- -
24
LT Borrowings
- -
- -
- -
LT Finance Leases
122
- -
108
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
88
- -
88
Market Capitalization
5,284
4,970
3,676

Working Capital

FRC

•

in mil. unless spec.
Mar'25
Jun'25
Sep'25
Total Current Assets
1,284
- -
1,272
Cash, Cash Equivalents & STI
51
- -
27
Accounts Receivable, Net
184
- -
209
Inventories
551
- -
497
Total Current Liabilities
628
- -
544
Payables & Accruals
- -
- -
- -
ST Debt
25
- -
24
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.04%
8.36%
3.46%
Free Cash Flow
-1,182.26%
19.28%
40.11%
Net Income, GAAP
14.84%
11.36%
-20.99%
Sales/Revenue/Turnover
8.24%
11.07%
7.82%
Total Cash Common Dividend
- -
6.49%
-46.52%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
470
504
535
580
2,089
2024
475
472
539
580
2,066
2025
490
560
550
628
2,228

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.57
0.69
- -
- -
3.25
2024
0.42
0.52
- -
- -
2.01
2025
0.18
0.52
- -
- -
1.61

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.1
2024
- -
- -
- -
- -
1.11
2025
- -
- -
- -
- -
0.6
Similar Companies
St.Shine Optical Co.,Ltd. (1565.TWO)
Remedent, Inc. (REMI)
Jin Medical International Ltd. (ZJYL)
Deltagen Inc. (DGEN)
Retractable Technologies, Inc. (RVP)
Azenta, Inc. (0HQ1.L)
Business
Carl Zeiss Meditec AG, a leading medical technology company listed on the MDAX and TecDAX indices of the German stock exchange (AFX.DE), develops and markets innovative technologies and application-oriented solutions for ophthalmology and microsurgery. The company offers one of the most comprehensive product portfolios in ophthalmology, including systems and consumables for cataract and corneal refractive surgery; diagnostic and therapeutic devices for managing chronic eye diseases such as glaucoma and retinal disorders; solutions for posterior eye segment diagnosis and treatment; and digitally connected workflow tools incorporating machine learning and artificial intelligence for data management and automation. In microsurgery, it provides complete visualization solutions for minimally invasive procedures in neurosurgery, ear-nose-throat surgery, spine surgery, plastic and reconstructive surgery, and dentistry. Founded in 2002 as a subsidiary of Carl Zeiss AG through the merger of ZEISS's ophthalmic business with laser technology maker Asclepion Meditec AG, the company is headquartered in Jena, Germany, with significant operations in over 50 countries, including major employee bases in the USA, Japan, Spain, France, India, and China. In April 2024, Carl Zeiss Meditec completed the acquisition of Dutch Ophthalmic Research Center (D.O.R.C.) from Eurazeo SE, integrating D.O.R.C.'s EVA NEXUS platform and vitreoretinal surgery portfolio to enhance its ophthalmic offerings, particularly in retina and posterior segment procedures, and to expand digitally connected end-to-end workflows for surgeons.